Neuron-glial interactions health and disease: from cognition to cancer
Michelle Leigh Monje-Deisseroth is a neuroscientist and neuro-oncologist. She is a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. She develops new treatments for diffuse intrinsic pontine glioma.For more information go tohttps://oir.nih.gov/walsAir date: 1/10/2024 2:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - July 28, 2023 Category: General Medicine Tags: Upcoming Events Source Type: video
Clinical Center Grand Rounds: Primary Cilia: Exploitable Glioma Signaling Hubs
Desmond A. Brown, MD, PhD, Assistant Clinical Investigator& Unit Head Neurosurgical Oncology Unit, Surgical Neurology Branch (SNB) National Institute of Neurological Disorders and Stroke, NINDSFor more information go tohttps://clinicalcenter.nih.gov/about/news/grcurrent.htmlAir date: 3/22/2023 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - February 23, 2023 Category: General Medicine Tags: Upcoming Events Source Type: video
COVID-19 SIG Lecture Series
Michelle Leigh Monje-Deisseroth is a neuroscientist and neuro-oncologist. She is a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. She develops new treatments for diffuse intrinsic pontine glioma. See https://med.stanford.edu/profiles/michelle-monje-deisseroth for more detailsFor more information go tohttps://www.niaid.nih.gov/research/covid-19-sigAir date: 10/6/2022 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - September 23, 2022 Category: General Medicine Tags: Upcoming Events Source Type: video
COVID-19 SIG Talk with Michelle Monje, Stanford University
Michelle Leigh Monje-Deisseroth is a neuroscientist and neuro-oncologist. She is a professor of neurology at Stanford University and an investigator with the Howard Hughes Medical Institute. She develops new treatments for diffuse intrinsic pontine glioma. See https://med.stanford.edu/profiles/michelle-monje-deisseroth for more detailsFor more information go tohttps://www.niaid.nih.gov/research/covid-19-sigAir date: 10/6/2022 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - August 26, 2022 Category: General Medicine Tags: Upcoming Events Source Type: video
The Peter Pan Syndrome: Oncohistones Stall Development in Pediatric Cancers
CCR Grand Rounds
Dr. Jabado ’ s research focuses on elucidating genetic signatures of pediatric astrocytomas and examining how they compare to adults. These are deadly brain tumors that originate in the brain and include glioblastomas (GBM, the highest grade of astrocytomas), which are one of the deadliest cancers in humans. Her group uncovered that pediatric high-grade astrocytomas (HGA) are molecularly and genetically distinct from adult tumors. They also identified a new molecular mechanism driving pediatric HGA, namely recurrent somatic driver mutations in the tail of histone 3 variants (H3.3 and H3.1). These mutatio...
Source: Videocast - All Events - October 21, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video
T Cell-Based Immunotherapy Approaches for Gliomas
NCI's Center for Cancer Research (CCR) Grand Rounds
As a physician – scientist, Dr. Okada has been dedicated to brain tumor immunology and development of effective immunotherapy for brain tumor patients for over 20 years. His team was one of very first to discover cytotoxic T lymphocyte (CTL) epitopes in glioma-associated and glioma-specific antigens. Dr. Okada also found critical roles for the integrin receptor very late activation antigen (VLA)-4 and the chemokine CXCL10 in facilitating entry of CTLs to the brain tumor site. Dr. Okada has translated these discoveries into a number of innovative immunotherapy clinical s...
Source: Videocast - All Events - December 11, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
Novel Personalized Care Directions for Gliomas
NCI ’ s Center for Cancer Research (CCR) Grand Rounds
Dr. Arnab Chakravarti is Chair and Professor of Radiation Oncology at the Arthur G. James Hospital, Richard J. Solove Research Institute, Ohio State University Comprehensive Cancer Center, where he also holds the Klotz Family Chair of Cancer Research and serves as the Director of the Brain Tumor Program. Nationally, he is Chair of the Board of Directors of the International Society of Neuro-Radiation Biology, Board of Directors of the Ohio Neuro-Oncology Consortium, Chair of the Radiation Therapy and Oncology Group (RTOG) Brain Tumor Translational Research Subcommitte...
Source: Videocast - All Events - September 5, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
